Skip to main content Back to Top
Advertisement

5/15/2019

Calcium Chloride Injection

Products Affected - Description

    • Calcium chloride intravenous injection, American Regent, 100 mg/mL, 10 mL vial, 10 count, NDC 00517-6710-10
    • Calcium chloride intravenous injection, Amphastar, 100 mg/mL, 10 mL Luer-Jet syringe, 10 count, NDC 76329-3304-01
    • Calcium chloride intravenous injection, Pfizer, 100 mg/mL, 10 mL Ansyr syringe, 10 count, NDC 00409-1631-10
    • Calcium chloride intravenous injection, Pfizer, 100 mg/mL, 10 mL LifeShield syringe, 10 count, NDC 00409-4928-34

Reason for the Shortage

    • American Regent did not provide a reason for the shortage.
    • Amphastar has calcium chloride on shortage due to increased demand.
    • Pfizer has calcium chloride on shortage due to manufacturing delays.
    • Mylan Institutional has withdrawn calcium chloride syringes from the market. The company recalled the syringes in April 2015 due to incompatibility of the syringes and some needless adaptors.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • American Regent has calcium chloride 100 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
    • Amphastar has calcium chloride 100 mg/mL 10 mL syringes available in limited supply.
    • Pfizer has calcium chloride 100 mg/mL 10 mL Ansyr syringes and 100 mg/mL 10 mL LifeShield syringes on back order and the company estimates a release date of August 2019.

Updated

Updated May 15, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 6, 2010 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins